Theravance Biopharma’s latest narrative update has nudged its fair value estimate slightly higher to about $26.71 per share, while the discount rate remains effectively unchanged. This modest shift ...
The Centers for Medicare and Medicaid Services (CMS) has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising a 44% cut that will save around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback